| __timestamp | Lantheus Holdings, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 176081000 | 4167274 |
| Thursday, January 1, 2015 | 157939000 | 5247851 |
| Friday, January 1, 2016 | 164073000 | 4925118 |
| Sunday, January 1, 2017 | 169243000 | 14930297 |
| Monday, January 1, 2018 | 168489000 | 25371768 |
| Tuesday, January 1, 2019 | 172526000 | 23921274 |
| Wednesday, January 1, 2020 | 200649000 | 25338236 |
| Friday, January 1, 2021 | 237513000 | 20182966 |
| Saturday, January 1, 2022 | 353358000 | 17562000 |
| Sunday, January 1, 2023 | 586886000 | 25212000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of the pharmaceutical industry, understanding cost structures is crucial. Over the past decade, Lantheus Holdings, Inc. and Pharming Group N.V. have showcased contrasting trajectories in their cost of revenue. From 2014 to 2023, Lantheus Holdings experienced a staggering 233% increase in costs, peaking in 2023. This growth reflects their aggressive expansion and investment in cutting-edge technologies. In contrast, Pharming Group N.V. maintained a more stable cost structure, with a modest 506% increase over the same period, indicating a strategic focus on efficiency and cost management.
The data reveals that while Lantheus Holdings' costs surged, Pharming Group N.V. managed to keep their expenses relatively contained. This comparison offers valuable insights into how different strategies can impact financial outcomes in the pharmaceutical sector.
Eli Lilly and Company vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Sanofi vs Lantheus Holdings, Inc.
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Analyzing Cost of Revenue: Viatris Inc. and Lantheus Holdings, Inc.
Analyzing Cost of Revenue: Intra-Cellular Therapies, Inc. and Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Pharming Group N.V.
Analyzing Cost of Revenue: Catalent, Inc. and Pharming Group N.V.
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Gross Profit Analysis: Comparing Pharming Group N.V. and Lantheus Holdings, Inc.
Lantheus Holdings, Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.